Paula Fraenkel

Paula Fraenkel

Company: AstraZeneca

Job title: Executive Director & Global Project Lead


Intratumoral mRNA Approach to Delivering Cytokine Immunotherapies 2:30 pm

Comparison to other approaches MEDI1191: IL12 mRNA mechanism of action and preclinical data Update of clinical, safety, and translational data from ongoing first-in-human clinical trial in combination with durvalumabRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.